mRNA Quality Monitoring Market To Reach $2.33 Billion By 2033

mRNA Quality Monitoring Market Growth & Trends

The global mRNA quality monitoring market size is projected to reach USD 2.33 billion by 2033, growing at a CAGR of 6.93% from 2025 to  2033, according to a new report by Grand View Research, Inc. As the sector concentrates on creating next-generation treatments that go beyond infectious diseases, there is an increasing need for reliable mRNA quality monitoring. Manufacturers are compelled to produce mRNA with greater consistency and reproducibility due to emerging applications in immunology, oncology, and rare genetic disorders. This change promotes the use of sophisticated quality control systems that can confirm important factors such as purity, poly(A) tail length, and capping efficiency at every stage of development, from research-scale batches to GMP manufacturing.

Another important driver of market expansion is technological innovation. Companies are spending money on high-throughput, automated analytical systems that reduce manual labor and error rates in quality control procedures. Integrating digital platforms and AI-driven data analytics makes real-time quality assessment, predictive analytics, and quicker decision-making possible. Due to these capabilities, manufacturers are gaining a competitive edge, significantly reducing development timelines and increasing compliance.

Furthermore, collaborations and strategic partnerships are expanding access to quality monitoring capabilities worldwide. Partnerships between mRNA developers, contract service providers, and analytical technology companies are creating a more connected ecosystem that allows small players to access advanced QC without building in-house capacity. Coupled with growing public and private funding for mRNA innovation, these collaborations are expected to sustain demand for QC kits, instruments, and services over the coming years.

 Request a free sample copy or view report summary: mRNA Quality Monitoring Market Report

mRNA Quality Monitoring Market Report Highlights

• By product & service, the kits/assays & reagents segment dominated the market, with the largest revenue share of 52.04% in 2024. These products enable rapid and reproducible testing for critical quality attributes such as mRNA integrity, capping efficiency, and residual impurities, reducing assay development time and regulatory risk.

• By technology, LC-MS segment is expected to grow at the fastest CAGR over the forecast period, driven by its high-resolution analysis of mRNA molecules, including sequence verification, detection of chemical modifications, and impurity profiling.

• By end use, the biopharmaceutical & biotechnology companies segment led the market with the largest revenue share of 55.79% in 2024. These companies require comprehensive QC solutions to ensure the integrity, purity, and potency of every batch, meeting stringent regulatory standards for clinical and commercial production.

mRNA Quality Monitoring Market Segmentation

Grand View Research has segmented the global mRNA quality monitoring market on the basis of product & service, technology, end use, and region:

mRNA Quality Monitoring Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

• Kits/Assays & Reagents 

• Instruments & Software

• QC Testing Services

mRNA Quality Monitoring Technology Outlook (Revenue, USD Million, 2021 - 2033)

• LC-MS 

• Electrophoresis

• ELISA 

• PCR Techniques

• Other Technologies

mRNA Quality Monitoring End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Biopharmaceutical & Biotechnology Companies 

• CDMOs, CROs & Analytical Labs 

• Academic & Research Institutes/Centers

mRNA Quality Monitoring Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the mRNA Quality Monitoring Market

• Revvity, Inc. 

• Agilent Technologies, Inc.

• Bio-Rad Laboratories, Inc. 

• Merck KGaA 

• Waters Corporation

• Creative Diagnostics

• GenScript

• TriLink BioTechnologies (Maravai LifeSciences)

• Creative Biolabs

• Vazyme International LLC